English | Español

Biospace
Patient Daily | Jun 10, 2026

ASCO conference highlights new cancer therapies and key clinical trial results
Patient Daily | Jun 10, 2026

Apogee Therapeutics secures $1.3B royalty deal, shares fall after eczema drug data
Patient Daily | Jun 10, 2026

Kailera Therapeutics enters catalyst-rich period after record-breaking IPO
Patient Daily | Jun 10, 2026

FDA delays decision on Beren Therapeutics’ rare disease drug by three months
Patient Daily | Jun 10, 2026

Summit Therapeutics’ PD-1/VEGF data to be presented at ASCO annual meeting
Patient Daily | Jun 9, 2026

Merck and Kelun report improved survival with new antibody-drug conjugate in lung cancer trial
Patient Daily | Jun 9, 2026

GSK acquires Nuvalent Bio for $10.6 billion in major oncology deal
Patient Daily | Jun 9, 2026

Merck and Gilead report mixed results in HIV and lung cancer drug trials

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures